RECRUITING

Molecular Basis for Variations in Hereditary Colorectal Cancer Syndromes

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Objectives: 1. To examine the variations in clinical features, survival outcomes, family history, and health behavior among proband patients who are known or suspected to have a hereditary colorectal cancer syndrome 2. To compare the clinical features, survival outcomes, and health behavior of the proband vs. his/her family members who may or may not be affected by the hereditary colorectal cancer syndrome 3. To explore for correlations between germline genetic variations in both the probands and family members with observed variations in the overall disease phenotype across probands and kindreds, within a given syndrome. Disease phenotype is defined to include: (1) clinicopathologic features including patient demographics and oncologic outcomes; (2) clinical manifestations of disease including the timing, spectrum and severity of CRC and extracolonic cancers. Genetic variations may include the specific codon mutated, the type of mutation and sequence alteration (e.g. nonsense, missense etc), chromosomal/gene copy number changes, and gene polymorphisms. 4. To explore for correlations between germline genetic variations in both the probands and family members with observed variations in somatic CRC tumor biology, including tumor pathology and other tumor molecular markers

Official Title

Molecular Basis for Variations in Hereditary Colorectal Cancer Syndromes

Quick Facts

Study Start:2012-05-22
Study Completion:2025-05-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT02863172

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Patient must have or is suspected to have a hereditary CRC syndrome
  2. 2. Patient must be at least 18 years of age at the time of study registration.
  3. 3. Patient must have sufficient command of the English language and mental capacity to provide consent
  4. 1. First- or second-degree relative of a registered MDACC patient who has met eligibility criteria for a Proband as defined above.
  5. 2. Family member must be at least 18 years of age at the time of study registration.
  6. 3. Family member must have sufficient command of the English language and mental capacity to provide consent
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Yi-Qian N. You, MD
CONTACT
713-792-6940
YNYou@mdanderson.org

Principal Investigator

Yi-Qian N. You, MD
PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center

Study Locations (Sites)

University of Texas MD Anderson Cancer Center
Houston, Texas, 77330
United States

Collaborators and Investigators

Sponsor: M.D. Anderson Cancer Center

  • Yi-Qian N. You, MD, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2012-05-22
Study Completion Date2025-05-30

Study Record Updates

Study Start Date2012-05-22
Study Completion Date2025-05-30

Terms related to this study

Keywords Provided by Researchers

  • Hereditary colorectal cancer syndrome
  • Questionnaires
  • Surveys
  • Blood sample
  • Saliva sample

Additional Relevant MeSH Terms

  • Hereditary Colorectal Cancer Syndrome